Search - tctmd.com

Displaying 881 - 900 of 1270

Sort: Relevancy | Date

News Conference News TCT 2012

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

October 25, 2012

Presentation TCT 2012

Culotte Stenting of a Left Main Distal Bifurcation Lesion

Presenter: Kazushige Kadota

October 25, 2012

Presentation TCT 2012

Case 3: A Complex Bifurcation with Two or More Stents(Culotte Stenting)

Presenter: John Ormiston

October 25, 2012

Presentation TCT 2012

Case 2: A Complex Bifurcation with Two Stents (T-Stenting)

Presenter: David Rizik

October 25, 2012

Presentation TCT 2012

The Balloon-Cushion Stenting Technique in Left Main Primary PCI

Presenter: Po-Ming Ku

October 24, 2012

Presentation TCT 2012

Severe Clinical Instability After Elective Stenting of the LCX and LAD: What Went Wrong?

Presenter: Mikko Pietila

October 24, 2012

Presentation TCT 2012

Case Presentation: Distal Left Main Stenting with Complications

Presenter: Kenneth Chin

October 24, 2012

Presentation TCT 2012

Case 3: IVUS Guided Stenting in Calcified Disease

Presenter: Rainer Hoffmann

October 24, 2012

Presentation TCT 2012

Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents)

Presenter: John Ormiston

October 24, 2012

Presentation TCT 2012

An Algorithmic Approach for (Non-Left Main) Bifurcation Stenting Based on Lesion Anatomy

Presenter: Issam Moussa

October 24, 2012

Presentation TCT 2012

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

Presenter: Hyeon-Cheol Gwon

October 24, 2012

Presentation TCT 2012

"Short- Versus Long-term Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Randomized Multicentre Trial." Circulation. 2012;125:2015-2026.

Presenter: Marco Valgimigli

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

Presentation TCT 2012

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Presenter: Christopher White

October 24, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Conference News TCT 2012

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

Presentation TCT 2012

TCT-2. Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000 Patients Enrolled in the SAPPHIRE Worldwide Study

Presenter: D. Christopher Metzger

October 23, 2012

Presentation TCT 2012

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Presenter: Klaudija Bijuklic

October 23, 2012

Presentation TCT 2012

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

Presenter: Fayaz Shawl

October 23, 2012

Advertisement

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

Culotte Stenting of a Left Main Distal Bifurcation Lesion

Case 3: A Complex Bifurcation with Two or More Stents(Culotte Stenting)

Case 2: A Complex Bifurcation with Two Stents (T-Stenting)

The Balloon-Cushion Stenting Technique in Left Main Primary PCI

Severe Clinical Instability After Elective Stenting of the LCX and LAD: What Went Wrong?

Case Presentation: Distal Left Main Stenting with Complications

Case 3: IVUS Guided Stenting in Calcified Disease

Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents)

An Algorithmic Approach for (Non-Left Main) Bifurcation Stenting Based on Lesion Anatomy

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

"Short- Versus Long-term Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Randomized Multicentre Trial." Circulation. 2012;125:2015-2026.

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

TCT-2. Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000 Patients Enrolled in the SAPPHIRE Worldwide Study

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content